+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 12Years +
All Genders
ID04074135

Study of the Natural History and Diagnosis of Pancreatic Tumors in Von Hippel-Lindau Disease Using 68-Gallium DOTATATE PETCT Scans

Led by National Cancer Institute (NCI) · Updated on 2026-10-16

740

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the natural history and management of pancreatic tumors in people with von Hippel-Lindau VHL disease, a condition that can cause tumors and cysts in various organs including the pancreas. This study aims to better understand these pancreatic neuroendocrine tumors and cystic lesions, and to evaluate whether adding a special scan called 68-Gallium DOTATATE PETCT can improve tumor detection. The study is a Phase 2 clinical trial focusing on the diagnostic aspects of VHL-related pancreatic tumors. Participants are divided into two groups one group will undergo yearly 68-Gallium DOTATATE PETCT research scans as part of their evaluation, while the other group will be observed without these research scans. Participants will have initial and follow-up visits that include physical exams by specialists, blood and urine tests, and imaging studies such as CT, PETCT, MRI, or ultrasound. The study will also collect genetic information and blood samples to discover biomarkers. Based on ongoing data analysis, surgical recommendations for pancreatic lesions may be updated. During the study, participants will be followed annually or every two years for life, depending on their disease status. Researchers will monitor tumor growth, time to surgery, and the predictive value of the PETCT scans. Evaluations include clinical exams, imaging, laboratory tests, and sample collections. All data will be securely stored and analyzed to characterize the clinical course of VHL pancreatic tumors and cysts over 15 years. The study is sponsored by the National Cancer Institute and aims to enroll up to 700 participants.

CONDITIONS

Brief Title

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Research Team

K

Kristine J Villaruel

N

Naris Nilubol, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here